logo BDSP

Base documentaire


  1. What factors influence the prescribing of antidepressant pharmacotherapy ? An assessment of national office-based encounters.

    Article - En anglais

    Objective 

    This study was designed to identify : 1) predictors of antidepressant pharmacotherapy among patients diagnosed with depression ; and 2) predictors of prescription for either a selective-serotonin reuptake inhibitor (SSRI), or a serotonin-norepinephrine reuptake inhibitor (SNRI).

    Method 

    Data from the 1995 National Ambulatory Medical Care urvey (NAMCS) were used to discern the number of office-based encounters documenting a diagnosis of depression (ICD-9-CM codes 296.2-296.36 ; 300.4 ; or 311) among patients eighteen years of age or older.

    Logistic regression-derived odds ratios (OR) and 95 percent confidence intervals (CI) were used to elucidate factors predictive of receipt of antidepressant pharmacotherapy, and, more specifically, factors predictive of receipt of an SSRI or an SNRI.

    Model variables included age (1849 years as compared to >= 50 years) ; race (white as compared to nonwhite, inclusive of Hispanics) ; gender ; self-report of depression as a reason for the office-based encounter ; and payer type (private insurance program as compared to public).

    Results 

    Among the estimated 18,046,293 office-based visits resulting in a diagnosis of depression, 56.2 percent of patients self-reported depression as a reason for the office-based encounter ; 67.5 percent were prescribed or continued a regimen of antidepressant pharmacotherapy ; and 48.3 percent were prescribed an SSRI or an SNRI. (...)

    Mots-clés Pascal : Etat dépressif, Prédiction, Prescription médicale, Chimiothérapie, Traitement, Inhibiteur recapture, Sérotonine, Noradrénaline, Antidépresseur, Psychotrope, Facteur sociodémographique, Age, Sexe, Assurance maladie, Etats Unis, Amérique du Nord, Amérique, Homme, Trouble humeur, Couverture sociale

    Mots-clés Pascal anglais : Depression, Prediction, Medical prescription, Chemotherapy, Treatment, Reuptake inhibitor, Serotonin, Norepinephrine, Antidepressant agent, Psychotropic, Sociodemographic factor, Age, Sex, Health insurance, United States, North America, America, Human, Mood disorder

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0361718

    Code Inist : 002B02B02. Création : 14/12/1999.